Montefiore Medical Center-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Montefiore Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013585
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Montefiore Medical Center (MMC) is a healthcare service provider that offers clinical services. The center offers services such as allergy and immunology, orthopaedics, dentistry and oral surgery, dermatology, endocrinology, digestive and liver diseases, neurological surgery, otorhinolaryngology, psychiatry and behavioral sciences. It offers services such as general internal medicine, women’s health, and wound care, advanced cancer surgery, among others. MMC offers services in the areas of nephrology, neurology, urology, women’s health, wound care and oncology, among others. The center operates through 50 primary care locations throughout the New York metropolitan area. MMC is headquartered in Bronx, New York, the US.

Montefiore Medical Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Montefiore Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Montefiore Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Montefiore Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Montefiore Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Montefiore Medical Center, Medical Devices Deals, 2011 to YTD 2017 10
Montefiore Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Montefiore Medical Center, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 13
Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 14
Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 15
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 16
Nanometics Enters into Co-Development Agreement with Albert Einstein College of Medicine for AIC-2011 17
The North Shore-LIJ Enters Into An Agreement With Montefiore Medical Center 18
Licensing Agreements 19
Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 19
Cue Biopharma Amends License Agreement with Albert Einstein 20
Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 21
CohBar Enters into Licensing Agreement with Regents of the University of California and Albert Einstein College of Medicine 22
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 24
Transgenomic Enters Into Licensing Agreement With Montefiore Medical 26
Acquisition 27
Montefiore Medical Center To Acquire New York Westchester Square Medical Center For US$15 Million 27
Montefiore Medical Center – Key Competitors 28
Montefiore Medical Center – Key Employees 29
Montefiore Medical Center – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 33
Government and Public Interest 33
Oct 03, 2016: Montefiore and Einstein Receive $3.7 Million NIH Grant to Study the Link Between Sleep Apnea and Childhood Obesity 33
Sep 21, 2016: Children’s Hospital at Montefiore Physician-In-Chief Awarded $5.3 Million NIH Grant To Study Environmental Influences On Child Health 34
Sep 07, 2016: Montefiore Receives $2 Million to Improve Health Habits at Two Bronx Primary Care Sites 35
Jul 28, 2016: Montefiore Einstein Physician-Researcher Awarded $4.2 Million National Institutes of Health Grant to Advance Asthma Care 36
Jul 28, 2016: Montefiore Einstein Physician Researcher Awarded $4.2 Million National Institutes of Health Grant to Advance Asthma Care 37
Apr 03, 2016: Two-Year Data Suggest Added Health Risks Of Combining Mitral-Valve Repair To Bypass Surgery With Little Benefit 38
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Montefiore Medical Center, Pharmaceuticals & Healthcare, Key Facts 2
Montefiore Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Montefiore Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Montefiore Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Montefiore Medical Center, Deals By Therapy Area, 2011 to YTD 2017 9
Montefiore Medical Center, Medical Devices Deals, 2011 to YTD 2017 10
Montefiore Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 13
Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 14
Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 15
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 16
Nanometics Enters into Co-Development Agreement with Albert Einstein College of Medicine for AIC-2011 17
The North Shore-LIJ Enters Into An Agreement With Montefiore Medical Center 18
Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 19
Cue Biopharma Amends License Agreement with Albert Einstein 20
Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 21
CohBar Enters into Licensing Agreement with Regents of the University of California and Albert Einstein College of Medicine 22
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 24
Transgenomic Enters Into Licensing Agreement With Montefiore Medical 26
Montefiore Medical Center To Acquire New York Westchester Square Medical Center For US$15 Million 27
Montefiore Medical Center, Key Competitors 28
Montefiore Medical Center, Key Employees 29
Montefiore Medical Center, Other Locations 31
Montefiore Medical Center, Subsidiaries 31

★海外企業調査レポート[Montefiore Medical Center-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Pack Corporation
    The Pack Corporation - Strategy, SWOT and Corporate Finance Report Summary The Pack Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • STEAG GmbH:電力:M&Aディール及び事業提携情報
    Summary STEAG GmbH (STEAG), formerly STEAG AG, a subsidiary of Kommunale Beteiligungsgesellschaft GmbH & Co. KG, is a power generation company that constructs, plans and operates power plants and distributed energy facilities. The company operates coal fired power plants. It offers services such as …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology company that offers research and clinical development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products such as MGN1703, MGN1601, MGN1404, MGN1331 and MGN1333. It uses proprietary platform technologi …
  • Aviakompaniya Sibir” OAO (P):企業の戦略・SWOT・財務分析
    Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report Summary Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BioView Ltd (BIOV):企業の財務・戦略的SWOT分析
    BioView Ltd (BIOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Contango Oil & Gas Co (MCF):石油・ガス:M&Aディール及び事業提携情報
    Summary Contango Oil & Gas Co (Contango) is an oil and natural gas company that explores, exploits, develops, produces and acquires crude oil and natural gas properties. The company provides operation for both offshore and onshore producing assets. Its offshore operations comprise Vermilion 170 plat …
  • Arcelik A.S. (ARCLK):企業の財務・戦略的SWOT分析
    Arcelik A.S. (ARCLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Zhuhai Holdings Investment Group Co Ltd:企業の戦略・SWOT・財務分析
    Zhuhai Holdings Investment Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zhuhai Holdings Investment Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Alaska Air Group, Inc.:企業の戦略・SWOT・財務情報
    Alaska Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alaska Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Enel SpA (ENEL):電力:M&Aディール及び事業提携情報
    Summary Enel SpA (Enel) is an integrated electricity and gas company that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on di …
  • Furukawa Electric Co Ltd (FUWAY):企業の財務・戦略的SWOT分析
    Furukawa Electric Co Ltd (FUWAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Cosmo Bio Co Ltd (3386):企業の財務・戦略的SWOT分析
    Summary Cosmo Bio Co Ltd (Cosmo Bio) is a medical device company that offers markets research reagents and research instruments. The company’s product categories include antibodies, assay and detection, cells and cell culture, bioactive substances, protein engineering, separation and purification, a …
  • Ocular Therapeutix Inc (OCUL):製薬・医療:M&Aディール及び事業提携情報
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …
  • Kier Group Plc (KIE):企業の財務・戦略的SWOT分析
    Kier Group Plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CDW Corporation:戦略・SWOT・企業財務分析
    CDW Corporation - Strategy, SWOT and Corporate Finance Report Summary CDW Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • EnCana Corporation:戦略・SWOT・企業財務分析
    EnCana Corporation - Strategy, SWOT and Corporate Finance Report Summary EnCana Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Alternatifbank A.S.:企業の戦略・SWOT・財務分析
    Alternatifbank A.S. - Strategy, SWOT and Corporate Finance Report Summary Alternatifbank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Dubai Electricity and Water Authority:電力:M&Aディール及び事業提携情報
    Summary Dubai Electricity and Water Authority (DEWA) is an electricity and water utility. It generates, transmits and distributes electricity; and desalinates water. The authority produces electricity using gas and steam turbines, and solar PV plants. DEWA’s plants include Jebel Ali Station D, E and …
  • Merus NV (MRUS):企業の財務・戦略的SWOT分析
    Summary Merus NV (Merus) is a clinical-stage immuno-oncology company that discovers and develops human bispecific antibody therapeutics for the treatment of cancer. The company’s pipeline antibody candidates are intended for the treatment of breast cancer, ovarian cancer, colorectal cancer, acute my …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆